Clinical Trial Update: Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update compares CKD-501 against pioglitazone when added to metformin in patients with Type 2 Diabetes Mellitus, reporting on efficac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CKD-501
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED